Literature DB >> 21382791

[Quality of life and psychological state in patients with choroidal melanoma: longitudinal study].

Agnieszka Suchocka-Capuano1, Anne Brédart, Sylvie Dolbeault, Livia Lumbroso-Le Rouic, Christine Lévy-Gabriel, Laurence Desjardins, Cécile Flahault, Catherine Bungener.   

Abstract

UNLABELLED: Treatments for choroidal melanoma (CM) generate largely unknown consequences on the level of the quality of life (QoL) and psychological state. Prospective published work is relatively rare and their results are not consistent. The objective of this study is to describe the QoL and psychological state's evolution in patients treated by conservative treatment for CM. POPULATION: Sixty-nine patients treated for CM by conservative treatment (proton beam irradiation or iodine plaques). QoL (EORTC-QLQ-C30 + QLQ-OPT-30), anxiety and depression (HADS, STAI-B-trait). DATA COLLECTION: Prospective study comprising four evaluations T0: before the beginning of the treatment, T1: one month, T2: six month, T3: one year after the treatment. The preliminary results of the first two evaluations showed that the level of the QoL remained relatively good and stable with an exception for the social functioning, which decreased after the treatment. More than half of the patients had a moderated rate of anxiety before the beginning of the treatment, which decreased significantly a month later. The depressive symptoms were lower and remained stable one month after the treatment. These results confirmed the importance of exploration and screening the fear of cancer recurrence among choroidal melanoma patients.

Entities:  

Mesh:

Year:  2011        PMID: 21382791     DOI: 10.1684/bdc.2011.1300

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  7 in total

Review 1.  Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies.

Authors:  Sébastien Simard; Belinda Thewes; Gerry Humphris; Mélanie Dixon; Ceara Hayden; Shab Mireskandari; Gozde Ozakinci
Journal:  J Cancer Surviv       Date:  2013-03-10       Impact factor: 4.442

2.  Impact of Adjuvant Ocular Interventions on the Quality of Life of Patients with Uveal Melanoma after Proton Beam Therapy.

Authors:  Johannes Gollrad; Christopher Rabsahl; Antonia M Joussen; Andrea Stroux; Volker Budach; Dirk Böhmer; Alexander Böker
Journal:  Ocul Oncol Pathol       Date:  2021-11-08

3.  Quality of Life Concerns in Patients with Uveal Melanoma after Initial Diagnosis.

Authors:  Christopher A Barker; Anna Kozlova; Alexander N Shoushtari; Jennifer L Hay; Jasmine H Francis; David H Abramson
Journal:  Ocul Oncol Pathol       Date:  2019-09-27

4.  Cost-effectiveness of proton beam therapy for intraocular melanoma.

Authors:  James P Moriarty; Bijan J Borah; Robert L Foote; Jose S Pulido; Nilay D Shah
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

Review 5.  Quality of Life, Depression, and Anxiety in Patients with Uveal Melanoma: A Review.

Authors:  Mario Miniati; Maria Grazia Fabrini; Federica Genovesi Ebert; Maricia Mancino; Alessandra Maglio; Gabriele Massimetti; Enrico Massimetti; Donatella Marazziti
Journal:  J Oncol       Date:  2018-03-20       Impact factor: 4.375

6.  Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma.

Authors:  Johannes Gollrad; Christopher Rabsahl; Aline-Isabel Riechardt; Jens Heufelder; Andrea Stroux; Ute Goerling; Antonia Joussen; Volker Budach; Dirk Boehmer
Journal:  Radiat Oncol       Date:  2021-09-08       Impact factor: 3.481

7.  Psychosocial impact of prognostic genetic testing in the care of uveal melanoma patients: protocol of a controlled prospective clinical observational study.

Authors:  Yesim Erim; Jennifer Scheel; Anja Breidenstein; Claudia Hd Metz; Dietmar Lohmann; Hans-Christoph Friederich; Sefik Tagay
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.